Efficacy of Human Islet Isolation From the Tail Section of the Pancreas for the Possibility of Living Donor Islet Transplantation

2004 ◽  
Vol 78 (6) ◽  
pp. 839-843 ◽  
Author(s):  
Shinichi Matsumoto ◽  
Koichi Tanaka ◽  
D Michael Strong ◽  
Jo Anna Reems
2018 ◽  
Vol 28 (2) ◽  
pp. 176-184 ◽  
Author(s):  
Heide Brandhorst ◽  
Paul R. Johnson ◽  
Johanna Mönch ◽  
Manfred Kurfürst ◽  
Olle Korsgren ◽  
...  

Although human islet transplantation has been established as valid and safe treatment for patients with type 1 diabetes, the utilization rates of human pancreases for clinical islet transplantation are still limited and substantially determined by the quality and composition of collagenase blends. While function and integrity of collagenase has been extensively investigated, information is still lacking about the most suitable supplementary neutral proteases. The present study compared islet isolation outcome after pancreas digestion by means of collagenase used alone or supplemented with either neutral protease (NP), clostripain (CP), or both proteases. Decent amounts of islet equivalents (IEQ) were isolated using collagenase alone (3090 ± 550 IEQ/g), or in combination with NP (2340 ± 450 IEQ/g) or CP (2740 ± 280 IEQ/g). Nevertheless, the proportion of undigested tissue was higher after using collagenase alone (21.1 ± 1.1%, P < 0.05) compared with addition of NP (13.3 ± 2.2%) or CP plus NP (13.7 ± 2.6%). Likewise, the percentage of embedded islets was highest using collagenase only (13 ± 2%) and lowest adding NP plus CP (4 ± 1%, P < 0.01). The latter combination resulted in lowest post-culture overall survival (42.7 ± 3.9%), while highest survival was observed after supplementation with CP (74.5 ± 4.8%, P < 0.01). An insulin response toward glucose challenge was present in all experimental groups, but the stimulation index was significantly decreased using collagenase plus NP (2.0 ± 0.12) compared with supplementation with CP (3.16 ± 0.4, P < 0.001). This study demonstrates for the first time that it is possible to isolate significant numbers of human islets combining collagenase only with CP. The supplementation with CP is an effective means to substantially reduce NP activity, which significantly decreases survival and viability after culture. This will facilitate the manufacturing of enzyme blends with less harmful characteristics.


2012 ◽  
Vol 21 (1) ◽  
pp. 39-47 ◽  
Author(s):  
R. Misawa ◽  
C. Ricordi ◽  
A. Miki ◽  
S. Barker ◽  
R. D. Molano ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-16 ◽  
Author(s):  
Yong Wang ◽  
Joshua E. Mendoza-Elias ◽  
Meirigeng Qi ◽  
Tricia A. Harvat ◽  
Sang Joon Ahn ◽  
...  

Islet transplantation is a promising therapy for type 1 diabetes mellitus; however, success rates in achieving both short- and long-term insulin independence are not consistent, due in part to inconsistent islet quality and quantity caused by the complex nature and multistep process of islet isolation and transplantation. Since the introduction of the Edmonton Protocol in 2000, more attention has been placed on preserving mitochondrial function as increasing evidences suggest that impaired mitochondrial integrity can adversely affect clinical outcomes. Some recent studies have demonstrated that it is possible to achieve islet cytoprotection by maintaining mitochondrial function and subsequently to improve islet transplantation outcomes. However, the benefits of mitoprotection in many cases are controversial and the underlying mechanisms are unclear. This article summarizes the recent progress associated with mitochondrial cytoprotection in each step of the islet isolation and transplantation process, as well as islet potency and viability assays based on the measurement of mitochondrial integrity. In addition, we briefly discuss immunosuppression side effects on islet graft function and how transplant site selection affects islet engraftment and clinical outcomes.


2015 ◽  
Vol 1 (5) ◽  
pp. 1-6 ◽  
Author(s):  
Magnus Ståhle ◽  
Aksel Foss ◽  
Bengt Gustafsson ◽  
Marko Lempinen ◽  
Torbjörn Lundgren ◽  
...  

protocols.io ◽  
2018 ◽  
Author(s):  
James Lyon ◽  
Patrick MacDonald ◽  
Jocelyn Manning

2005 ◽  
Vol 37 (8) ◽  
pp. 3427-3429 ◽  
Author(s):  
S. Matsumoto ◽  
T. Okitsu ◽  
Y. Iwanaga ◽  
H. Noguchi ◽  
H. Nagata ◽  
...  

2017 ◽  
Vol 101 (10) ◽  
pp. 2321-2329 ◽  
Author(s):  
Andrew R. Pepper ◽  
Antonio Bruni ◽  
Rena Pawlick ◽  
John Wink ◽  
Yasmin Rafiei ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document